{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PTGX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:07:02.001Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":671,"canonical_name":"Protagonist Therapeutics, Inc","cik":"0001377121","uei":null,"lei":null,"duns":null,"ticker":"PTGX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":49},"count":49,"timeline":[{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Protagonist Therapeutics, Inc — 2026-10-02","url_slug":"/sec/cik-0001377121/4/0001104659-26-113279","accession_number":"0001104659-26-113279","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"144","title":"144 — Protagonist Therapeutics, Inc — 2026-09-30","url_slug":"/sec/cik-0001377121/144/0001950047-26-009883","accession_number":"0001950047-26-009883","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Protagonist Therapeutics, Inc — 2026-08-13","url_slug":"/sec/cik-0001377121/schedule-13g-a/0000908834-26-000405","accession_number":"0000908834-26-000405","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Protagonist Therapeutics, Inc — 2026-08-07","url_slug":"/sec/cik-0001377121/schedule-13g/0000093751-26-000527","accession_number":"0000093751-26-000527","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/10-q/0001104659-26-091123","accession_number":"0001104659-26-091123","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/8-k/0001104659-26-091099","accession_number":"0001104659-26-091099","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8","title":"S-8 — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8/0001104659-26-091226","accession_number":"0001104659-26-091226","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091233","accession_number":"0001104659-26-091233","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091235","accession_number":"0001104659-26-091235","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091236","accession_number":"0001104659-26-091236","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091239","accession_number":"0001104659-26-091239","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091241","accession_number":"0001104659-26-091241","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091242","accession_number":"0001104659-26-091242","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091245","accession_number":"0001104659-26-091245","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091249","accession_number":"0001104659-26-091249","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091254","accession_number":"0001104659-26-091254","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091257","accession_number":"0001104659-26-091257","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8 POS","title":"S-8 POS — Protagonist Therapeutics, Inc — 2026-08-05","url_slug":"/sec/cik-0001377121/s-8-pos/0001104659-26-091259","accession_number":"0001104659-26-091259","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Protagonist Therapeutics, Inc — 2026-06-25","url_slug":"/sec/cik-0001377121/4/0001104659-26-077761","accession_number":"0001104659-26-077761","importance":30},{"ts":"2026-06-23","kind":"sec.form144","reporter":"WILLIAM WADDILL","title":"Director","shares":9000,"usd_value":1035270,"security_title":"Common","approx_sale_date":"2026-06-23","accession_number":"0001950047-26-006422","importance":40.207054},{"ts":"2026-06-23","kind":"sec.insider.s","reporter":"Waddill William D.","title":"","shares":9000,"price_per_share":117.94,"usd_value":1061460,"security_title":"Common Stock","importance":36.06146},{"ts":"2026-06-23","kind":"sec.filing","form_type":"144","title":"144 — Protagonist Therapeutics, Inc — 2026-06-23","url_slug":"/sec/cik-0001377121/144/0001950047-26-006422","accession_number":"0001950047-26-006422","importance":30},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Waddill William D.","title":"","shares":9000,"price_per_share":16.54,"usd_value":148860,"security_title":"Common Stock","importance":15.148859999999999},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Protagonist Therapeutics, Inc — 2026-06-18","url_slug":"/sec/cik-0001377121/8-k/0001104659-26-075777","accession_number":"0001104659-26-075777","importance":35},{"ts":"2026-06-11","kind":"sec.filing","form_type":"4","title":"4 — Protagonist Therapeutics, Inc — 2026-06-11","url_slug":"/sec/cik-0001377121/4/0001104659-26-073049","accession_number":"0001104659-26-073049","importance":30},{"ts":"2026-06-10","kind":"sec.form144","reporter":"WILLIAM WADDILL","title":"Director","shares":9000,"usd_value":952830,"security_title":"Common","approx_sale_date":"2026-06-10","accession_number":"0001950047-26-005894","importance":40.190566},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"Waddill William D.","title":"","shares":9000,"price_per_share":107.68,"usd_value":969120,"security_title":"Common Stock","importance":35.96912},{"ts":"2026-06-10","kind":"sec.filing","form_type":"144","title":"144 — Protagonist Therapeutics, Inc — 2026-06-10","url_slug":"/sec/cik-0001377121/144/0001950047-26-005894","accession_number":"0001950047-26-005894","importance":30},{"ts":"2026-06-10","kind":"sec.insider.m","reporter":"Waddill William D.","title":"","shares":6000,"price_per_share":16.54,"usd_value":99240,"security_title":"Common Stock","importance":15.09924},{"ts":"2026-06-10","kind":"sec.insider.m","reporter":"Waddill William D.","title":"","shares":3000,"price_per_share":11.8,"usd_value":35400,"security_title":"Common Stock","importance":15.0354},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Protagonist Therapeutics, Inc — 2026-06-01","url_slug":"/sec/cik-0001377121/4/0001104659-26-069047","accession_number":"0001104659-26-069047","importance":30},{"ts":"2026-05-29","kind":"sec.insider.s","reporter":"Waddill William D.","title":"","shares":9000,"price_per_share":99.64,"usd_value":896760,"security_title":"Common Stock","importance":35.89676},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Waddill William D.","title":"","shares":9000,"price_per_share":11.8,"usd_value":106200,"security_title":"Common Stock","importance":15.1062},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Protagonist Therapeutics, Inc — 2026-05-12","url_slug":"/sec/cik-0001377121/schedule-13g/0000093751-26-000283","accession_number":"0000093751-26-000283","importance":55},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"Protagonist Therapeutics, Inc","shares":3116804,"percent_of_class":4.9,"security_title":"SCHEDULE 13G","accession_number":"0000093751-26-000283","excerpt":null,"importance":55},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"PATEL DINESH V PH D","title":"President and CEO","shares":75000,"price_per_share":100.12,"usd_value":7509000,"security_title":"Common Stock","importance":42.509},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"PATEL DINESH V PH D","title":"President and CEO","shares":75000,"price_per_share":100.12,"usd_value":7509000,"security_title":"Common Stock","importance":42.509},{"ts":"2026-05-12","kind":"sec.form144","reporter":"Dinesh Patel","title":"CEO","shares":75000,"usd_value":7762500,"security_title":"Common","approx_sale_date":"2026-05-12","accession_number":"0001968582-26-000430","importance":41.5525},{"ts":"2026-05-12","kind":"sec.insider.m","reporter":"PATEL DINESH V PH D","title":"President and CEO","shares":75000,"price_per_share":21.58,"usd_value":1618500,"security_title":"Common Stock","importance":16.6185},{"ts":"2026-05-12","kind":"sec.insider.m","reporter":"PATEL DINESH V PH D","title":"President and CEO","shares":75000,"price_per_share":21.58,"usd_value":1618500,"security_title":"Common Stock","importance":16.6185},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Protagonist Therapeutics, Inc — 2026-05-11","url_slug":"/sec/cik-0001377121/4/0001104659-26-058860","accession_number":"0001104659-26-058860","importance":30},{"ts":"2026-05-08","kind":"sec.form144","reporter":"BRYAN M  & COURTNEY L GIRAUDO RT","title":"Director","shares":11130,"usd_value":1113000,"security_title":"Common","approx_sale_date":"2026-05-08","accession_number":"0001950047-26-004264","importance":40.2226},{"ts":"2026-05-08","kind":"sec.insider.s","reporter":"Giraudo Bryan","title":"","shares":6000,"price_per_share":100,"usd_value":600000,"security_title":"Common Stock","importance":35.6},{"ts":"2026-05-08","kind":"sec.insider.s","reporter":"Giraudo Bryan","title":"","shares":5130,"price_per_share":100,"usd_value":513000,"security_title":"Common Stock","importance":35.513},{"ts":"2026-05-08","kind":"sec.filing","form_type":"144","title":"144 — Protagonist Therapeutics, Inc — 2026-05-08","url_slug":"/sec/cik-0001377121/144/0001950047-26-004264","accession_number":"0001950047-26-004264","importance":30},{"ts":"2026-05-07","kind":"sec.insider.s","reporter":"Giraudo Bryan","title":"","shares":36000,"price_per_share":100.14,"usd_value":3605040,"security_title":"Common Stock","importance":38.60504},{"ts":"2026-05-07","kind":"sec.insider.s","reporter":"Giraudo Bryan","title":"","shares":12000,"price_per_share":100.07,"usd_value":1200840,"security_title":"Common Stock","importance":36.20084},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Giraudo Bryan","title":"","shares":24000,"price_per_share":6.45,"usd_value":154800,"security_title":"Common Stock","importance":15.1548},{"ts":"2026-05-07","kind":"sec.insider.m","reporter":"Giraudo Bryan","title":"","shares":12000,"price_per_share":6.98,"usd_value":83760,"security_title":"Common Stock","importance":15.08376}]}